Masupirdine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameMasupirdine
Drug Alias NameM1 of SUVN-502SUVN-502SVN-502M-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonists
TargetsSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsAgitationAlzheimer DiseaseInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandSerbia +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesUniversity Of Oxford
Active IndicationsAgitationAlzheimer Disease
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A